新冠疫苗人體實驗：一批志愿者已注射疫苗

Human Vaccine trial gets underway

新冠疫苗人體試驗

vaccine /'væksi?n/ n. 疫苗;痘苗

The first clinical trial of the novel coronavirus vaccine in China has begun, and photos and videos of volunteers taking part in the project began to circulate on social media over the weekend.

我國展開新冠肺炎疫苗Ⅰ期臨床試驗，周末志愿者參與該項目的照片和視頻開始在社交媒體上流傳。

The phase 1 clinical trial for recombinant novel coronavirus vaccine was registered on March 17, according to the Chinese Clinical Trial Registry. The COVID-19 vaccine was jointly developed by the Institute of Biotechnology, the Academy of Military Medical Sciences of the People's Liberation Army, and Tianjin-based CanSino Biologics Inc.

根據(jù)中國臨床試驗注冊中心消息，重組新型冠狀病毒疫苗Ⅰ期臨床試驗于本月17日注冊通過，由軍事科學(xué)院軍事醫(yī)學(xué)研究院和天津的康希諾生物股份公司聯(lián)合研發(fā)。

The trial is being conducted on 108 healthy adults ages 18 to 60 in two medical facilities in Wuhan, Hubei province.

試驗在湖北武漢兩家醫(yī)療機(jī)構(gòu)里108名年齡為18-60歲的健康的成年人中展開。

The trial is expected to be completed by Dec 31, according to the registry.

注冊信息顯示，試驗將于12月31日前完成。

As a subunit vaccine, it contains only a fragment of the pathogen to stimulate a protective immune response.

該疫苗為亞單位疫苗，只含有刺激保護(hù)性免疫反應(yīng)的病原體片段。

The volunteers will receive a series of follow-up examinations in the six months after being injected to see if their bodies have generated an antibody to the virus.

未來半年里，接種疫苗的志愿者將接受一系列的后續(xù)檢查，以觀察他們的身體是否產(chǎn)生對抗病毒的抗體。